Adriaan van der Meer

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Carla Perez, Gideon M. Hirschfield, Christophe Corpechot et al. · Alimentary Pharmacology & Therapeutics · 2019 · 116 citations · Full text

Medicine, Clinical Sciences, Pathology +17

Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

Christophe Corpechot, Fabrice Carrat, Farid Gaouar et al. · Journal of Hepatology · 2022 · 116 citations · Full text

Veterinary Medicine, Radiology, Hepatology +16

Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

Christophe Corpechot, Sara Lemoinne, Pierre‐Antoine Soret et al. · Hepatology · 2023 · 78 citations · Full text

Medicine, Internal Medicine, Hepatology +13

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis

Romée J.A.L.M. Snijders, Anna Stoelinga, Tom J.G. Gevers et al. · Journal of Hepatology · 2023 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis

Alessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O’Donnell et al. · Clinical Gastroenterology and Hepatology · 2020 · 56 citations · Full text

Medicine, Internal Medicine, Hepatology +12